Latest News about Ocugen Inc/

Recent news which mentions Ocugen Inc/

Lab Notes: Imvax advances brain cancer treatment; Wistar identifies promising compound for HIV patients

March 31, 2023

Lab Notes: Fox Chase Cancer Center researcher gets $1M grant; NRx raises funds

March 10, 2023

Lab Notes: Wedgewood Pharmacy acquires Colorado lab; Aprea Therapeutics raises $5.5M

March 03, 2023

Lab Notes: Drexel and Bancroft team up to advance autism research; AmerisourceBergen forms new partnership

February 03, 2023

Lab Notes: Neuronetics resolves lawsuit; Harmony CEO departs; Ocugen issues results of Covaxin study

January 13, 2023

Lab Notes: Chimeron Bio names new CEO; Amicus Therapeutics gets positive opinion for rare disease therapy

December 23, 2022

Lab Notes: Cabaletta signs licensing deal for up to $162M; merger unites life sciences tech providers

October 14, 2022

Lab Notes: Integral Molecular has first submission for new FDA pilot program; Jefferson ALS program expanding

September 09, 2022

Ocugen's efforts to bring Covid-19 vaccine Covaxin to U.S. boosted by positive study results in children

June 21, 2022

Lab Notes: Endo gets U.S. rights to potential knee pain drug; Optinose stock climbs after positive study results

June 17, 2022

Ocugen gets rights to Mexico in expanded Covaxin deal with Bharat Biotech

April 18, 2022

Ocugen's study of Covid-19 vaccine Covaxin put on hold in wake of WHO inspection of Bharat

April 12, 2022

Lab Notes: Venatorx closes Series C financing; Ocugen takes 'critical' step in clinical trial

April 08, 2022

Lab Notes: Chimeron's Covid-19 vaccine candidate shows promise; Lannett gets 2nd NYSE delisting notice

March 25, 2022

Ocugen's stock plummets after FDA rejects emergency use bid for Covid vaccine

March 04, 2022

Ocugen expects $53.5M from stock sale amid efforts to bring Covaxin to the U.S.

February 24, 2022

Ocugen signs letter of intent to buy Canadian pharmaceutical manufacturing plant

January 27, 2022

Lab Notes: Strata Skin Sciences makes acquisition; Cabaletta Bio promotes 2 executives

January 14, 2022

Lab Notes: Trevena advances new pain drug; Ocugen receives good news from FDA

December 17, 2021

FDA places a hold on Ocugen's plan for U.S. trials of the Covid-19 vaccine Covaxin

November 30, 2021

Ocugen applies for emergency FDA authorization for use of its Covid-19 vaccine in children

November 05, 2021

Lab Notes: Trice gets FDA approval for device; Ocugen files to begin Covid-19 vaccine trial

October 29, 2021

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.